Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Amgen Inc. AMGN
$232.25
-$0.04 (-0.02%)
На 18:00, 12 мая 2023
+10.08%
Потенциал через год
Ранг: 1
Ключевые показатели
-
Marketcap
124001268747.00000000
-
week52high
296.67
-
week52low
223.30
-
Revenue
26323000000
-
P/E TTM
48
-
Beta
0.64152200
-
EPS
14.29000000
-
Last Dividend
8.52000000
-
Next Earnings Date
02 авг 2023 г. в 10:59
Описание компании
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Atlantic Equities | Underweight | Underweight | 09 авг 2022 г. |
| RBC Capital | Sector Perform | Sector Perform | 05 авг 2022 г. |
| Piper Sandler | Overweight | Overweight | 05 авг 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 15 июл 2022 г. |
| Oppenheimer | Outperform | Outperform | 01 июн 2022 г. |
| Barclays | Equal-Weight | Equal-Weight | 12 окт 2022 г. |
| Morgan Stanley | Overweight | Equal-Weight | 11 окт 2022 г. |
| Barclays | Underweight | Equal-Weight | 31 окт 2022 г. |
| RBC Capital | Sector Perform | Sector Perform | 04 ноя 2022 г. |
| Piper Sandler | Overweight | Overweight | 04 ноя 2022 г. |
| Morgan Stanley | Overweight | Overweight | 04 ноя 2022 г. |
| Credit Suisse | Underperform | 18 ноя 2022 г. | |
| Oppenheimer | Outperform | Outperform | 06 дек 2022 г. |
| Wells Fargo | Equal-Weight | Equal-Weight | 03 янв 2023 г. |
| SVB Leerink | Market Perform | Market Perform | 22 дек 2022 г. |
| Piper Sandler | Overweight | Overweight | 13 дек 2022 г. |
| SVB Leerink | Market Perform | Market Perform | 02 февр 2023 г. |
| Wells Fargo | Equal-Weight | Equal-Weight | 01 февр 2023 г. |
| RBC Capital | Sector Perform | Sector Perform | 01 февр 2023 г. |
| Oppenheimer | Outperform | Outperform | 01 февр 2023 г. |
| Cowen & Co. | Outperform | Outperform | 01 февр 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Khosla Rachna | D | 6630 | 387 | 09 ноя 2022 г. |
| Kullman Ellen Jamison | A | 10113 | 222 | 08 ноя 2022 г. |
| Drake Michael V | A | 810 | 171 | 08 ноя 2022 г. |
| ISHRAK OMAR | A | 2302 | 222 | 08 ноя 2022 г. |
| Grygiel Nancy A. | D | 13009 | 545 | 08 ноя 2022 г. |
| Louie Linda H. | D | 9278 | 45 | 05 ноя 2022 г. |
| Miller Derek | D | 5973 | 63 | 05 ноя 2022 г. |
| Khosla Rachna | D | 7017 | 168 | 05 ноя 2022 г. |
| Grygiel Nancy A. | D | 13554 | 240 | 05 ноя 2022 г. |
| Louie Linda H. | D | 9323 | 125 | 02 ноя 2022 г. |
Institutional Ownership
Institutional Ownership
| Holder | Shares | Change | Date Reported |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 16578100 | -142937 | 31 авг 2020 г. |
| Vanguard 500 Index Fund | 12087000 | -43658 | 31 авг 2020 г. |
| Invesco QQQ Trust | 6709940 | 103101 | 31 авг 2020 г. |
| SPDR S&P 500 ETF | 6204490 | -29382 | 31 авг 2020 г. |
| SPDR Dow Jones Industrial Average ETF | 5450750 | 5450750 | 31 авг 2020 г. |
| Fidelity 500 Index Fund | 5239790 | -5670 | 31 июл 2020 г. |
| Vanguard PRIMECAP Fund | 10430800 | -96100 | 30 июн 2020 г. |
| American Funds Capital Income Builder | 7612560 | -722122 | 30 июн 2020 г. |
| American Funds Investment Company of America | 7462040 | 408490 | 30 июн 2020 г. |
| American Funds American Mutual Fund | 6446800 | 100000 | 30 июн 2020 г. |
Новостная лента
May Dogs Of The Dow: Buy 2, Watch 4
Seeking Alpha
10 мая 2023 г. в 19:12
"The Dow adds a stock if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation is also a consideration.” - Dow Jones & Co. The highest-yield 10 stocks are May's Dogs of the Dow: JNJ, GS, CSCO, AMGN, CVX, DOW, IBM, MMM, WBA, and VZ, averaged a 4.65% annual yield.
TScan Therapeutics stock soars after Amgen collaboration on Crohn's disease treatment that could bring in more than $500 million
Market Watch
09 мая 2023 г. в 09:15
Shares of TScan Therapeutics Inc. TCRX powered up 43.1% in premarket trading Tuesday, after the biopharmaceutical company announced a collaboration with Amgen Inc. AMGN to treat Crohn's disease that could be worth more than $500 million to TScan. Amgen shares slipped 0.1% ahead of the open.
16 Stocks Run Circles Around Warren Buffett Over The Long Haul
Investors Business Daily
09 мая 2023 г. в 08:00
Warren Buffett held court again at Berkshire Hathaway's shareholder meeting. But his company could learn from some other S&P 500 companies.
2 Best Biotech Stocks to Buy Right Now
The Motley Fool
06 мая 2023 г. в 07:55
Eli Lilly and Amgen both boast exceptional product portfolios and pipelines. The two companies pay growing dividends to shareholders.
2 Magnificent Dividend Stocks to Buy Before the Next Recession
The Motley Fool
05 мая 2023 г. в 09:45
Both of these drugmakers have rich pipelines that will allow them to recover from recent sales slumps. They also offer above-average dividend yields and have raised their payouts regularly over the last five years.